Skip to main content

A do-nothing Congress isn't healthy

By John E. Porter, Special to CNN
August 16, 2013 -- Updated 1450 GMT (2250 HKT)
STORY HIGHLIGHTS
  • Former congressman John Porter says Congress has done little up to August recess
  • Among the issues he says Congress hasn't tackled is more funding for health research
  • He says people support more spending, and most would pay more taxes for research
  • Porter: Health research is an investment that will benefit our childen and grandchildren

Editor's note: John Porter, who served for 21 years as a Republican congressman from Illinois, is chairman of Research!America, an alliance which represents academic, industry, patient groups and other organizations, to advocate for greater public investment in research for health. The alliance is primarily funded by member organizations including pharmaceutical companies and philanthropists. He is a partner in the law firm of Hogan & Lovells.

(CNN) -- At every congressional recess, the question remains: What has Congress accomplished to advance medical innovation, or for that matter any of our national priorities?

A ritual of leaving town with no meaningful action on pressing issues seems to have taken hold as lawmakers once again meet with voters in their districts. Indeed, much will happen during this break, but as elected officials hold yet another town hall meeting, Facebook or Twitter chat or public event, thousands will be diagnosed with cancer or get the dreaded confirmation from a physician that they or a loved one has Alzheimer's disease. Thousands will suffer a heart attack or stroke, and thousands of parents will learn that their child has a rare disease.

Researchers are racing against the clock to identify a new gene or molecule that could lead to the next medical breakthrough and bring us closer to cures and new therapies to halt disease.

John E. Porter
John E. Porter

Time is of the essence in the scientific community, but unfortunately, our elected leaders continue to squander precious time in political, ideological battles that yield little or no results. Is this the Congress you elected? This is not the first elected body to tackle formidable challenges, but it may be the first that has failed miserably in addressing critical issues that will have short- and long-term implications for the health and well-being of Americans.

Spending bills to fund the National Institutes of Health, the Centers for Disease Control and other agencies in the next fiscal year remain in limbo as sequestration, across-the-board spending cuts enacted in March, tightens its grip on medical innovation. As a result of these mindless budget cuts, researchers are delaying or scrubbing promising studies. Institutions across the country have closed labs, reduced their work forces and implemented hiring freezes. Young scientists are rethinking their career paths or moving abroad to countries that have accelerated investments in research.

Many commentators have noted that the 113th Congress is on track to be the least productive in recent history. Fewer than three dozen bills have been passed by this Congress and signed into law.

This new style of legislating, when there is any, seems to be brinksmanship at the last possible moment: Hail Mary passes to avert a government shutdown and the like. If the head of a Fortune 500 company performed in this manner, he would be given the boot. Perhaps voters should think the same of those obstructionists on Capitol Hill who block action on measures to advance science and innovation the next time they head to the polls. In the meantime, it's important for all of us who care about the future of biomedical and health research to get engaged.

It's a myth that members of Congress don't pay attention in the month of August. On the contrary, during this recess, they are meeting with their constituents to at least shore up support for their next campaigns.

This is the time to tell them that voters are expecting action, not more heated rhetoric. It's time to tell them that tax and entitlement reform is essential -- rational proposals that will reduce health care costs and sustain investments in research and development. Research and development is now classified as an investment rather than an expense by the Bureau of Economic Analysis in calculating the gross domestic product, a sensible approach in recognizing the value of R&D in generating future income and bolstering our economy.

Now, if only our esteemed leaders in Washington will do likewise. They must abandon the notion that research isn't highly valued by most Americans compared with bread-and-butter issues. In fact, more than half of Americans are willing to spend more in taxes if they were certain that all of the money would be spent on additional medical research, according to polling (PDF) commissioned by Research!America, a nonprofit advocacy alliance.

Americans understand the importance of a long-term investment in medical and health research to spur private-sector innovation and produce the therapies, medical devices and treatments that will save lives. The importance of long-term priorities is, by the way, one of the ways a nation stands apart from a corporation beholden to shareholder demands for immediate return.

A nation's leadership must view research through the prism of future generations: our children and grandchildren, who will benefit from both a health and economic standpoint as a result of today's scientific discoveries. Imagine a world free of cancer, free of AIDS, free of Alzheimer's, free of heart disease. It's certainly possible if elected officials get beyond the rhetoric and take decisive action to strengthen our nation's investments in research.

Follow us on Twitter @CNNOpinion.

Join us on Facebook/CNNOpinion.

The opinions expressed in this commentary are solely those of John E. Porter.

ADVERTISEMENT
Part of complete coverage on
December 26, 2014 -- Updated 1617 GMT (0017 HKT)
Today's politicians should follow Ronald Reagan's advice and invest in science, research and development, Fareed Zakaria says.
December 26, 2014 -- Updated 1319 GMT (2119 HKT)
Artificial intelligence does not need to be malevolent to be catastrophically dangerous to humanity, writes Greg Scoblete.
December 26, 2014 -- Updated 1505 GMT (2305 HKT)
Historian Douglas Brinkley says a showing of Sony's film in Austin helped keep the city weird -- and spotlighted the heroes who stood up for free expression
December 26, 2014 -- Updated 1303 GMT (2103 HKT)
Tanya Odom that by calling only on women at his press conference, the President made clear why women and people of color should be more visible in boardrooms and conferences
December 26, 2014 -- Updated 1312 GMT (2112 HKT)
When oil spills happen, researchers are faced with the difficult choice of whether to use chemical dispersants, authors say
December 25, 2014 -- Updated 0633 GMT (1433 HKT)
Danny Cevallos says the legislature didn't have to get involved in regulating how people greet each other
December 23, 2014 -- Updated 2312 GMT (0712 HKT)
Marc Harrold suggests a way to move forward after the deaths of NYPD officers Wenjian Liu and Rafael Ramos.
December 24, 2014 -- Updated 1336 GMT (2136 HKT)
Simon Moya-Smith says Mah-hi-vist Goodblanket, who was killed by law enforcement officers, deserves justice.
December 24, 2014 -- Updated 1914 GMT (0314 HKT)
Val Lauder says that for 1,700 years, people have been debating when, and how, to celebrate Christmas
December 23, 2014 -- Updated 2027 GMT (0427 HKT)
Raphael Sperry says architects should change their ethics code to ban involvement in designing torture chambers
December 24, 2014 -- Updated 0335 GMT (1135 HKT)
Paul Callan says Sony is right to call for blocking the tweeting of private emails stolen by hackers
December 23, 2014 -- Updated 1257 GMT (2057 HKT)
As Christmas arrives, eyes turn naturally toward Bethlehem. But have we got our history of Christmas right? Jay Parini explores.
December 23, 2014 -- Updated 0429 GMT (1229 HKT)
The late Joe Cocker somehow found himself among the rock 'n' roll aristocracy who showed up in Woodstock to help administer a collective blessing upon a generation.
December 23, 2014 -- Updated 2115 GMT (0515 HKT)
History may not judge Obama kindly on Syria or even Iraq. But for a lame duck president, he seems to have quacking left to do, says Aaron Miller.
December 23, 2014 -- Updated 1811 GMT (0211 HKT)
Terrorism and WMD -- it's easy to understand why these consistently make the headlines. But small arms can be devastating too, says Rachel Stohl.
December 22, 2014 -- Updated 1808 GMT (0208 HKT)
Ever since "Bridge-gate" threatened to derail Chris Christie's chances for 2016, Jeb Bush has been hinting he might run. Julian Zelizer looks at why he could win.
December 20, 2014 -- Updated 1853 GMT (0253 HKT)
New York's decision to ban hydraulic fracturing was more about politics than good environmental policy, argues Jeremy Carl.
December 20, 2014 -- Updated 2019 GMT (0419 HKT)
On perhaps this year's most compelling drama, the credits have yet to roll. But we still need to learn some cyber lessons to protect America, suggest John McCain.
December 22, 2014 -- Updated 2239 GMT (0639 HKT)
Conservatives know easing the trade embargo with Cuba is good for America. They should just admit it, says Fareed Zakaria.
December 20, 2014 -- Updated 0112 GMT (0912 HKT)
We're a world away from Pakistan in geography, but not in sentiment, writes Donna Brazile.
December 19, 2014 -- Updated 1709 GMT (0109 HKT)
How about a world where we have murderers but no murders? The police still chase down criminals who commit murder, we have trials and justice is handed out...but no one dies.
December 18, 2014 -- Updated 2345 GMT (0745 HKT)
The U.S. must respond to North Korea's alleged hacking of Sony, says Christian Whiton. Failing to do so will only embolden it.
December 19, 2014 -- Updated 2134 GMT (0534 HKT)
President Obama has been flexing his executive muscles lately despite Democrat's losses, writes Gloria Borger
ADVERTISEMENT